To investigate the relationship between cellular Nrf2 expression levels and resistance to ACA-28, we used the A549 human lung cancer cell line, which harbors the Keap1 mutation expressing high Nrf2 protein levels [27]. The gene discussed is KEAP1; the disease is lung carcinoma.